Aspergillus PCR formidable challenges and progress

Medical Mycology

Volumn 47, Issue SUPPL. 1, 2009, Pages

  Klingspor, Lena ^a   Loeffler, Juergen ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Aspergillus; Diagnostic PCR; PCR

Indexed keywords

EDETIC ACID; FUNGAL DNA;

ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; ASPERGILLOSIS; ASPERGILLUS; BLOOD CULTURE; CANDIDA; DIAGNOSTIC TEST; DNA EXTRACTION; DNA PURIFICATION; FALSE NEGATIVE RESULT; FUNGAL DETECTION; FUNGEMIA; GENE AMPLIFICATION; HUMAN; IMMUNOCOMPROMISED PATIENT; INCIDENCE; INVASIVE ASPERGILLOSIS; MORBIDITY; MORTALITY; NONHUMAN; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; SENSITIVITY AND SPECIFICITY; DIAGNOSTIC PROCEDURE; GENETICS; ISOLATION AND PURIFICATION; LUNG ASPERGILLOSIS; METHODOLOGY; REVIEW;

ASPERGILLUS; CANDIDA; EQUUS ASINUS; FUNGI;

ASPERGILLUS; HUMANS; INVASIVE PULMONARY ASPERGILLOSIS; MOLECULAR DIAGNOSTIC TECHNIQUES; NEUROASPERGILLOSIS; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

EID: 67651083813     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1080/13693780802616823     Document Type: Article

References (43)

1. Chanock SJ, Pizzo PA. Infectious complications of patients undergoing therapy for acute leukemia: Current status and future prospects. Semin Oncol 1997; 2: 132-140.
2. Wald A, Leisenring W, van Burik JA, et al. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. J Infect Dis 1997; 175: 1459-1466.
3. Denning DW, Marinus A, Cohen J, et al. An EORTC multicentre prospective survey of invasive aspergillosis in haematological patients: diagnosis and therapeutic outcome. J Infect 1998; 37: 173-180.
4. Morgan J, Wannemuehler KA, Marr KA, et al. Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: Interim results of a prospective multicenter surveillance program. Med Mycol 2005; 43: S49-S58.
5. Meyer MH, Letscher-Bru V, Jaulhac B, et al. Comparison of mycosis IC/F and plus aerobic/F media for diagnosis of fungemia by the Bactec 9240 system. J Clin Microbiol 2004; 42: 773-777.
6. McDonald LC, Weinstein MP, Fune J, et al. Controlled comparison of BacT/ALERT FANaerobic medium and BACTEC fungal blood culture medium for detection of fungemia. J Clin Microbiol 2001; 39: 622-624.
7. Verweij PE, Meis JF. Microbiological diagnosis of invasive fungal infections in transplant recipients. Transpl Infect Dis 2000; 2 80-87.
8. Kim MJ, Lee KS, Kim J, et al. Crescent sign in invasive pulmonary aspergillosis: Frequency and related CT and clinical factors. J Comput Assist Tomogr 2001; 25: 305-310.
9. Caillot D, Couaillier JF, Bernard A, et al. Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia. J Clin Oncol 2001; 19: 253-259.
10. Horger M, Einsele H, Schumacher U, et al. Invasive pulmonary aspergillosis: Frequency and meaning of the 'hypodense sign' on unenhanced CT. Br J Radiol 2005; 55: 437-444.
11. Ascioglu S, Rex JH, de Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus. Clin Infect Dis 2002; 34: 7-14.
12. Miyazaki T, Kohno S, Mitsutake K, et al. Plasma (1->3)-beta-Dglucan and fungal antigenemia in patients with candidemia, aspergillosis, and cryptococcosis. J Clin Microbiol 1995; 33 3115-3118.
13. Odabasi Z, Mattiuzzi G, Estey E, et al. Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: Validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin Infect Dis 2004; 39: 199-205.
14. Einsele H, Hebert H, Roller G, et al. Detection and identification of fungal pathogens in blood by using molecular probes. J Clin Microbiol 1997; 35: 1353-1360.
15. Loeffler J, Hebart H, Sepe S, et al. Detection of PCR-amplified fungal DNA by using a PCR-ELISA system. Med Mycol 1998; 36: 275-279.
16. Kami M, Fukui T, Ogawa S, et al. Use of real-time PCR on blood samples for diagnosis of invasive aspergillosis. Clin Infect Dis 2001; 33: 1504-1512.
17. Lass-Florl C, Gunsilius E, Gastl G, et al. Clinical evaluation of Aspergillus-PCR for detection of invasive aspergillosis in immunosuppressed patients. Mycoses 2005; 48: S12-S7.
18. Klingspor L, Jalal S. Molecular detection and identification of Candida and Aspergillus spp. from clinical samples using real-time PCR. Clin Microbiol Infect 2006; 12: 745-753.
19. Lewis White P, Barnes RA. Aspergillus. PCR - Platforms, strengths and weaknesses. Med Mycol 2006; 44: S191-S198.
20. Schabereiter-Gurtner C, Selitsch B, Rotter ML, et al. Development of novel real-time PCR assays for detection and differentiation of eleven medically important Aspergillus and Candida species in clinical specimens. J Clin Microbiol 2007; 45: 906-914.
21. Simoneau E, Kelly M, Labbe AC, et al. What is the clinical significance of positive blood cultures with Aspergillus sp in hematopoietic stem cell transplant recipients? A 23 year experience. Bone Marrow Transplant 2005; 35: 303-306.
22. Loeffler J, Hebart H, Brauchle U, et al. Comparison between plasma and whole blood specimens for detection of Aspergillus DNA by PCR. J Clin Microbiol 2000; 38: 3830-3833.
23. White PL, Barton R, Guiver M, et al. A consensus on fungal polymerase chain reaction diagnosis?: A United Kingdom-Ireland evaluation of polymerase chain reaction methods for detection of systemic fungal infections. J Mol Diagn 2006; 8: 376-384.
24. Garcia ME, Blanco JL, Caballero J, Gargallo-Viola D. Anticoagulants interfere with PCR used to diagnose invasive aspergillosis. J Clin Microbiol 2002; 40: 1567-1568.
25. Paterson PJ, Seaton S, McLaughlin J, Kibbler CC. Development of molecular methods for the identification of Aspergillus and emerging moulds in paraffin wax embedded tissue sections. Mol Pathol 2003; 56: 368-370.
26. Griffiths LJ, Anyim M, Doffman SR, et al. Comparison of DNA extraction methods for Aspergillus fumigatus using real-time PCR. J Med Microbiol 2006; 55: 1187-1191.
27. Rimek D, Garg AP, Haas WH, Kappe R. Identification of contaminating fungal DNA sequences in Zymolyase. J Clin Microbiol 1999; 37 830-831.
28. Loeffler J, Herbart H, Bialek R, et al. Contaminations occurring in fungal PCR assays. J Clin Microbiol 2000; 38: 3830-3833.
29. Rickerts V, Just-Nübling G, Konrad F, et al. Diagnosis of invasive aspergillosis and mucormucosis in immunocompromised patients by seminested PCR assay of tissue samples. Eur J Clin Microbiol Infect Dis 2006; 25: 8-13.
30. Williamson EC, Leeming JP, Palmer HM, et al. Diagnosis of invasive aspergillosis in bone marrow transplant recipients by polymerase chain reaction. Br J Haematol 2000; 108: 132-139.
31. White PL, Linton CJ, Perry MD, Johnson EM, Barnes RA. The evolution and evaluation of a whole blood polymerase chain reaction assay for the detection of invasive aspergillosis in hematology patients in a routine clinical setting. Clin Infect Dis 2006; 42: 479-486.
32. Lau A, Chen S, Sorrell T, et al. Development and clinical application of a panfungal PCR assay to detect and identify fungal DNA in tissue specimens. J Clin Microbiol 2007; 45: 380-385.
33. Florent M, Katsahian S, Vekhoff A, et al. Prospective evaluation of a polymerase chain reaction-ELISA targeted to Aspergillus fumigatus and Aspergillus flavus for the early diagnosis of invasive aspergillosis in patients with hematological malignancies. J Infect Dis 2006; 193: 741-747.
34. Buchheidt D, Hummel M, Schleiermacher D, et al. Prospective clinical evaluation of a LightCycler-mediated polymerase chain reaction assay, a nested-PCR assay and a galactomannan enzymelinked immunosorbent assay for detection of invasive aspergillosis in neutropenic cancer patients and haematological stem cell transplant recipients. Br J Haematol 2004; 125: 196-202.
35. Kawazu M, Kanda Y, Nannya Y, et al. Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked immunosorbent assay for galactomannan, and a (1->3)-beta-D-glucan test in weekly screening for invasive aspergillosis in patients with hematological disorders. J Clin Microbiol 2004; 42: 2733-2741.
36. Hebart H, Löffler J, Meisner C, et al. Early detection of Aspergillus infection after allogeneic stem cell transplantation by polymerase chain reaction screening. J Infect Dis 2000; 181: 1713-1719.
37. Jensen HE, Salonen J, Ekfors TO. The use of immunohistochemistry to improve sensitivity and specificity in the diagnosis of systemic mycoses in patients with haematological malignancies. J Pathol 1997; 181: 100-105.
38. Walsh TJ, Finberg RW, Arndt C, et al. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. N Eng J Med 1999; 340: 764-771.
39. Buchheidt D, Baust C, Skladny H, et al. Clinical evaluation of a polymerase chain reaction assay to detect Aspergillus species in bronchoalveolar lavage samples of neutropenic patients. Br J Haematol 2002; 116: 803-811.
40. Francesconi A, Kasai M, Petraitiene R, et al. Characterization and comparison of galactomannan enzyme immunoassay and quantitative real-time PCR assay for detection of Aspergillus fumigatus in bronchoalveolar lavage fluid from experimental invasive pulmonary aspergillosis. J Clin Microbiol 2006; 44: 2475-2480.
41. Raad I, Hanna H, Huaringa A, et al. Diagnosis of invasive pulmonary aspergillosis using polymerase chain reaction-based detection of Aspergillus in BAL. Chest 2002; 121: 1171-1176.
42. Hummel M, Spiess B, Kentouche K, et al. Detection of Aspergillus DNA in cerebrospinal fluid from patients with cerebral aspergillosis by a nested PCR assay. J Clin Microbiol 2006; 44 3989-3993.
43. Khan ZU, Ahmad S, Mokaddas E, et al. Cerebral aspergillosis diagnosed by detection of Aspergillus flavus-specific DNA, galactomannan and (1->3)-beta-D-glucan in clinical specimens. J Med Microbiol 2007; 56: 129-132.